UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

Chronic Thromboembolic Pulmonary Hypertension

JAMA : the journal of the American Medical Association, 2024-03, Vol.331 (11), p.972

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification and management of pediatric venous thromboembolism in the emergency department

Pediatric emergency medicine practice, 2024-05, Vol.21 (5), p.1

2024

Link zum Volltext

Verfügbarkeit prüfen

Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study

Thrombosis research, 2024-04, Vol.236, p.130-135

2024

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism: diagnostic advances and unaddressed challenges in management

Current opinion in hematology, 2024-05, Vol.31 (3), p.122

2024

Link zum Volltext

Verfügbarkeit prüfen

Direct Oral Anticoagulants vs. Conventional Anticoagulants for the Treatment of VTE

American family physician, 2024-03, Vol.109 (3), p.210

2024

Link zum Volltext

Verfügbarkeit prüfen

Design and validation of algorithms to identify venous thromboembolism in the French National Healthcare Database

Pharmacoepidemiology and drug safety, 2024-04, Vol.33 (4), p.e5781-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study

Thrombosis research, 2024-03, Vol.235, p.32-40

2024

Link zum Volltext

Verfügbarkeit prüfen

Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty

Scientific reports, 2024-03, Vol.14 (1), p.5955-5955

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis

Blood coagulation & fibrinolysis, 2024-04, Vol.35 (3), p.101

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeted prophylactic anticoagulation based on the TRiP(cast) score in patients with lower limb immobilisation: a multicentre, stepped wedge, randomised implementation trial

The Lancet (British edition), 2024-03, Vol.403 (10431), p.1051-1060

2024

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism chemical prophylaxis after skull base surgery

Acta neurochirurgica, 2024-04, Vol.166 (1), p.165-165

2024

Link zum Volltext

Verfügbarkeit prüfen

Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative

Thrombosis research, 2024-04, Vol.236, p.68-73

2024

Link zum Volltext

Verfügbarkeit prüfen

Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis

Critical care medicine, 2024-05, Vol.52 (5), p.811

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis

Seminars in thrombosis and hemostasis, 2024-04, Vol.50 (3), p.328

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-world experience of direct oral anticoagulant use in a single pediatric center

Pediatric blood & cancer, 2024-05, Vol.71 (5), p.e30926-e30926

2024

Link zum Volltext

Verfügbarkeit prüfen

Improved precision in defining the need for thromboprophylaxis during lower limb immobilisation

The Lancet (British edition), 2024-03, Vol.403 (10431), p.999-1001

2024

Link zum Volltext

Verfügbarkeit prüfen

Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial

PloS one, 2024-04, Vol.19 (4), p.e0298152-e0298152

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries

PloS one, 2024-03, Vol.19 (3), p.e0298596-e0298596

2024

Link zum Volltext

Verfügbarkeit prüfen

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease

Journal of the American Heart Association, 2024-02, Vol.13 (4), p.e028957-e028957

2024

Link zum Volltext

Verfügbarkeit prüfen

Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients

Scientific reports, 2024-03, Vol.14 (1), p.6831-6831

2024

Link zum Volltext

Verfügbarkeit prüfen

Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study

Thrombosis research, 2024-04, Vol.236, p.127-129

2024

Link zum Volltext

Verfügbarkeit prüfen

Management of venous thromboembolism in patients with active cancer

Cleveland Clinic journal of medicine, 2024-02, Vol.91 (2), p.109-117

2024

Link zum Volltext

Verfügbarkeit prüfen

VTE with Amivantamab plus Chemotherapy in NSCLC

The New England journal of medicine, 2024-02, Vol.390 (6), p.578-580

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma

Journal of neuro-oncology, 2024-02, Vol.166 (3), p.569-574

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 219

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(167)
Thromboembolism
(151)
Science & Technology
(139)
Life Sciences & Biomedicine
(133)
Thrombosis
(84)
Patients
(67)
Risk Factors
(64)
Anticoagulants
(58)
Venous Thromboembolism - Drug Therapy
(56)
Anticoagulants - Therapeutic Use
(53)
Venous Thromboembolism
(50)
Retrospective Studies
(39)
Cardiovascular System & Cardiology
(37)
General & Internal Medicine
(34)
Hematology
(34)
Medicine, General & Internal
(32)
Anticoagulants - Adverse Effects
(31)
Female
(31)
Venous Thromboembolism - Prevention & Control
(29)
Mortality
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(35)

Menü

Weitere Dienste

Einstellungen

Chronic Thromboembolic Pulmonary Hypertension

Identification and management of pediatric venous thromboembolism in the emergency department

Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study

Venous thromboembolism: diagnostic advances and unaddressed challenges in management

Direct Oral Anticoagulants vs. Conventional Anticoagulants for the Treatment of VTE

Design and validation of algorithms to identify venous thromboembolism in the French National Healthcare Database

Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2

Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study

Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty

Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis

Targeted prophylactic anticoagulation based on the TRiP(cast) score in patients with lower limb immobilisation: a multicentre, stepped wedge, randomised implementation trial

Venous thromboembolism chemical prophylaxis after skull base surgery

Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative

Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis

Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis

Real-world experience of direct oral anticoagulant use in a single pediatric center

Improved precision in defining the need for thromboprophylaxis during lower limb immobilisation

Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease

Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients

Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study

Management of venous thromboembolism in patients with active cancer

VTE with Amivantamab plus Chemotherapy in NSCLC

Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma

Aktive Filter

Suchergebnisse filtern